First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
University of Kentucky
Start Date
February 1, 2019
End Date
November 30, 2022
Administered By
School of Medicine
Awarded By
University of Kentucky
Start Date
February 1, 2019
End Date
November 30, 2022